Lowe's Loses Even as Wall Street Shrugs Off 'Turnaround Stumble'




Lowe
Lowe's Loses Even as Wall Street Shrugs Off 'Turnaround Stumble'  

(Bloomberg) -- Lowe's Cos Inc. analysts still see opportunity for the home-improvement retailer, even after an unexpected first-quarter earnings miss sparked the worst intraday stock tumble in more than a decade.

"We view the quarter's gross margin miss as a classic early turnaround stumble," Loop Capital Markets analyst Laura Champine wrote. "Lowe's has a new CEO and an even newer CFO, so we are not alarmed that the company is struggling to manage cost pressures."

Shares dropped as much as 12% Wednesday, eating away at the stock's year-to-date gains, which had reached ~27% by mid-April. Lowe's posted its first-quarter results before the market opened Wednesday.

Champine said she expects the company's margin issues to be short term and kept a hold rating with a $102 price target. Although its business in Canada will likely continue to drag on the company, she said management seems focused on the U.S. locations and has faith that "Lowe's new management team will eventually be successful in tightening the company's execution gap."

Analysts are broadly bullish on the home-improvement retailer, with Bloomberg data showing 22 buy recommendations, 10 holds and no sells. The average analyst price target of $117 implies potential return of ~19%.

Here's what others on Wall Street are saying:

Baird, Peter Benedict

Weakness is a "good long-term buying opportunity" after the company posted lower-than-expected gross margins as cost pressures converge, likely because of tariffs, promotional activity and ineffective legacy pricing processes.

Rates outperform; Price target $133

RBC Capital Markets, Scot Ciccarelli

Lowe's was dragged on by "cost pressures, merchandising team transitions and less-effective pricing tools" during the quarter, likely due to heavy promotions and clearance activity. Ciccarelli expects investors to be tuned in to "Lowe's ability to gain market share vs. Home Depot given its better comp performance in the quarter." Still, it may not be sustainable given an easier comparison for Lowe's, support from better in-stocks and inventory loading, and a promotional stance.

Rates outperform; Price target $120

Morgan Stanley, Simeon Gutman

Lowe's was likely highly promotional in the first quarter, didn't fully understand its product acquisition costs and also "did not realize how promotional it was being due to outdated technology." The results are a "meaningful setback for the transformation story" and investors will be wondering how fast the company can solve the gross margin issue and how badly it will hurt sales.

Rates overweight; Price target $123

Here's what Bloomberg Intelligence says:

"Lowe's failure to drive gross-margin expansion in 1Q, despite 3.5% same-store sales growth, highlights the severity of the issues it could face as it continues its turnaround. Management's lack of visibility and understanding of certain business processes established by prior leadership may pose problems that will delay and hinder margin flowthrough."--Seema Shah, Senior retail analyst

To contact the reporter on this story: Sydney Maki in New York at smaki8@bloomberg.net

To contact the editors responsible for this story: Brad Olesen at bolesen3@bloomberg.net, Morwenna Coniam

For more articles like this, please visit us at bloomberg.com

©2019 Bloomberg L.P.

COMMENTS

More Related News

Billionaires From Soros to Pritzker Heirs Urge Wealth Tax
Billionaires From Soros to Pritzker Heirs Urge Wealth Tax

(Bloomberg) -- Some of the richest people in the U.S. are calling for a federal wealth tax.Financier George Soros, heiresses Liesel and Regan Pritzker, Abigail Disney and Facebook Inc. co-founder Chris Hughes are among those calling for the levy to help address income inequality and provide funding to

Bristol-Myers Will Divest Celgene Blockbuster to Close Deal
Bristol-Myers Will Divest Celgene Blockbuster to Close Deal

Under an agreement with the Federal Trade Commission, Bristol-Myers will sell off the psoriasis pill Otezla to appease antitrust regulators' concerns, the company said in a statement. Bristol-Myers shares fell as much as 7% to $45.89 in New York, the biggest intraday drop since the deal was announced on Jan. 3. Celgene declined as much as 4.7% to $94.26.

Protests Erupt in Caracas During Venezuela Visit by UN
Protests Erupt in Caracas During Venezuela Visit by UN's Bachelet

(Bloomberg) -- United Nations High Commissioner for Human Rights Michelle Bachelet called on the Venezuelan government to release political prisoners."I call on the authorities to free all those who are detained for peacefully exercising their civil and political rights," Bachelet said via webcast before departing Venezuela after a three-day visit.The UN will leave two officials in Caracas to provide technical assistance and to more closely monitor the country's human rights situation, Bachelet said. Venezuela's government also agreed to an evaluation of the national commission on torture prevention and another study of the obstacles to accessing the justice system, she said.Protests...

China Meat Imports Hit Record as Pork Prices Jump on Swine Fever
China Meat Imports Hit Record as Pork Prices Jump on Swine Fever

(Bloomberg) -- China, the world's top pork consumer, imported a record volume of meat in May in a bid to mitigate the impact of African swine fever as domestic pork prices rebound.China bought 556,276 tones of meat and offal in May, up about 45% from a year earlier, according to official customs data

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Economy

facebook
Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.